Tina Bugge Pedersen
Norwegian University of Science and Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tina Bugge Pedersen.
Journal of Magnetic Resonance Imaging | 2005
Marte Thuen; Trond E. Singstad; Tina Bugge Pedersen; Olav Haraldseth; Martin Berry; Axel Sandvig; Christian Brekken
To evaluate manganese (Mn2+)‐enhanced MRI in a longitudinal study of normal and injured rat visual projections.
Journal of Magnetic Resonance Imaging | 2008
Marte Thuen; Martin Berry; Tina Bugge Pedersen; Pål Erik Goa; Mike Summerfield; Olav Haraldseth; Axel Sandvig; Christian Brekken
To provide dose‐response data for the safe and effective use of MnCl2 for manganese (Mn2+) ‐enhanced MRI (MEMRI) of the visual pathway.
Journal of Magnetic Resonance Imaging | 2009
Marte Thuen; Øystein Olsen; Martin Berry; Tina Bugge Pedersen; Anders Kristoffersen; Olav Haraldseth; Axel Sandvig; Christian Brekken
To evaluate manganese (Mn2+)‐enhanced MRI (MEMRI) and diffusion tensor imaging (DTI) as tools for detection of axonal injury and regeneration after intravitreal peripheral nerve graft (PNG) implantation in the rat optic nerve (ON).
NeuroImage | 2006
C. Brekke; Arvid Lundervold; Per Øyvind Enger; Christian Brekken; E. Stålsett; Tina Bugge Pedersen; Olav Haraldseth; P.G. Krüger; Rolf Bjerkvig; Martha Chekenya
Tumour angiogenesis is a tightly regulated process involving cross-talk between tumour cells and the host tissue. The underlying mechanisms that regulate such interactions remain largely unknown. NG2 is a transmembrane proteoglycan whose presence on transformed cells has been demonstrated to increase proliferation in vitro and angiogenesis in vivo. To study the effects of NG2 during tumour growth and progression, we engineered an NG2 positive human glioma cell line (U251-NG2) from parental NG2 negative cells (U251-WT) and implanted both cell types stereotactically into immunodeficient nude rat brains. The tumours were longitudinally monitored in vivo using multispectral MRI employing two differently sized contrast agents (Gd-DTPA-BMA and Gadomer) to assess vascular leakiness, vasogenic oedema, tumour volumes and necrosis. Comparisons of Gd-DTPA-BMA and Gadomer revealed differences in their spatial distribution in the U251-NG2 and U251-WT tumours. The U251-NG2 tumours exhibited a higher leakiness of the larger molecular weight Gadomer and displayed a stronger vasogenic oedema (69.9 +/- 15.2, P = 0.018, compared to the controls (10.7 +/- 7.7). Moreover, immunohistochemistry and electron microscopy revealed that the U251-NG2 tumours had a higher microvascular density (11.81 +/- 0.54; P = 0.0010) compared to controls (5.76 +/- 0.87), with vessels that displayed larger gaps between the endothelial cells. Thus, tumour cells can regulate both the function and structure of the host-derived tumour vasculature through NG2 expression, suggesting a role for NG2 in the cross-talk between tumour-host compartments.
NMR in Biomedicine | 2010
Line R. Jensen; Else Marie Huuse; Tone F. Bathen; Pål Erik Goa; Anna M. Bofin; Tina Bugge Pedersen; Steinar Lundgren; Ingrid S. Gribbestad
The purpose of this study was to evaluate the use of dynamic contrast‐enhanced (DCE) MRI, in vivo 1H MRS and ex vivo high resolution magic angle spinning (HR MAS) MRS of tissue samples as methods to detect early treatment effects of docetaxel in a breast cancer xenograft model (MCF‐7) in mice. MCF‐7 cells were implanted subcutaneously in athymic mice and treated with docetaxel (20, 30, and 40 mg/kg) or saline six weeks later. DCE‐MRI and in vivo 1H MRS were performed on a 7 T MR system three days after treatment. The dynamic images were used as input for a two‐compartment model, yielding the vascular parameters Ktrans and ve. HR MAS MRS, histology, and immunohistochemical staining for proliferation (Ki‐67), apoptosis (M30 cytodeath), and vascular/endothelial cells (CD31) were performed on excised tumor tissue. Both in vivo spectra and HR MAS spectra were used as input for multivariate analysis (principal component analysis (PCA) and partial least squares regression analysis (PLS)) to compare controls to treated tumors. Tumor growth was suppressed in docetaxel‐treated mice compared to the controls. The anti‐tumor effect led to an increase in Ktrans and ve values in all the treated groups. Furthermore, in vivo MRS and HR MAS MRS revealed a significant decrease in choline metabolite levels for the treated groups, in accordance with reduced proliferative index as seen on Ki‐67 stained sections. In this study DCE‐MRI, in vivo MRS and ex vivo HR MAS MRS have been used to demonstrate that docetaxel treatment of a human breast cancer xenograft model results in changes in the vascular dynamics and metabolic profile of the tumors. This indicates that these MR methods could be used to monitor intra‐tumoral treatment effects. Copyright
NeuroImage | 2009
Marius Widerøe; Øystein Olsen; Tina Bugge Pedersen; Pål Erik Goa; Annemieke Kavelaars; Cobi J. Heijnen; Jon Skranes; Ann-Mari Brubakk; Christian Brekken
Hypoxic-ischemic injury (HI) to the neonatal brain results in delayed neuronal death with accompanying inflammation for days after the initial insult. The aim of this study was to depict delayed neuronal death after HI using Manganese-enhanced MRI (MEMRI) and to evaluate the specificity of MEMRI in detection of cells related to injury by comparison with histology and immunohistochemistry. 7-day-old Wistar rat pups were subjected to HI (occlusion of right carotid artery and 8% O(2) for 75 min). 16 HI (HI+Mn) and 6 sham operated (Sham+Mn) pups were injected with MnCl(2) (100 mM, 40 mg/kg) and 10 HI-pups (HI+Vehicle) received NaCl i.p. 6 h after HI. 3D T(1)-weighted images (FLASH) and 2D T(2)-maps (MSME) were acquired at 7 T 1, 3 and 7 days after HI. Pups were sacrificed after MR-scanning and brain slices were cut and stained for CD68, GFAP, MAP-2, Caspase-3 and Fluorojade B. No increased manganese-enhancement (ME) was detectable in the injured hemisphere on day 1 or 3 when immunohistochemistry showed massive ongoing neuronal death. 7 days after HI, increased ME was seen on T(1)-w images in parts of the injured cortex, hippocampus and thalamus among HI+Mn pups, but not among HI+Vehicle or Sham+Mn pups. Comparison with immunohistochemistry showed delayed neuronal death and inflammation in these areas with late ME. Areas with increased ME corresponded best with areas with high concentrations of activated microglia. Thus, late manganese-enhancement seems to be related to accumulation of manganese in activated microglia in areas of neuronal death rather than depicting neuronal death per se.
Journal of Magnetic Resonance Imaging | 2011
Axel Sandvig; Ioanna Sandvig; Martin Berry; Øystein Olsen; Tina Bugge Pedersen; Christian Brekken; Marte Thuen
To assess optic nerve (ON) regeneration after injury by applying manganese‐enhanced MRI (MEMRI) in a study of comparative physiology between nonregenerating rat and mouse species and regenerating frog and fish species.
Neonatology | 2011
Marius Widerøe; Christian Brekken; Annemieke Kavelaars; Tina Bugge Pedersen; Pål Erik Goa; Cobi J. Heijnen; Jon Skranes; Ann-Mari Brubakk
Background: Hypoxia-ischemia (HI) in the neonatal brain results in a prolonged injury process. Longitudinal studies using noninvasive methods can help elucidate the mechanisms behind this process. We have recently demonstrated that manganese-enhanced magnetic resonance imaging (MRI) can depict areas with activated microglia and astrogliosis 7 days after hypoxic-ischemic brain injury. Objective: The current study aimed to follow brain injury after HI in rats longitudinally and compare manganese enhancement of brain areas to the development of injury and presence of reactive astrocytes and microglia. Methods: The Vannucci model for hypoxic-ischemic injury in the neonatal rat was used. Pups were injected with either MnCl2 or saline after 6 h and again on day 41 after HI. Longitudinal MRI (T1 weighted) was performed 1, 3, 7 and 42 days after HI. The brains were prepared for immunohistochemistry after the final MRI. Results: There was severe loss of cerebral tissue from day 7 to day 42 after HI. Most manganese-enhanced areas in the hippocampus, thalamus and basal ganglia at day 7 were liquefied after 42 days. Manganese-enhancement on day 42 corresponded to areas of activated microglia and reactive astrocytes in the remaining cortex, hippocampus and amygdala. However, the main area of enhancement was in the remaining thalamus in a calcified area surrounded by activated microglia and reactive astrocytes. Conclusion: Manganese-enhanced MRI can be a useful tool for in vivo identification of cerebral tissue undergoing delayed cell death and liquefaction after HI. Manganese enhancement at a late stage seems to be related to the accumulation of manganese in calcifications and gliotic tissue.
Journal of Neurosurgery | 2006
Peter C. Huszthy; Christian Brekken; Tina Bugge Pedersen; Frits Thorsen; Per Øystein Sakariassen; Kai Ove Skaftnesmo; Olav Haraldseth; Per Eystein Lønning; Rolf Bjerkvig; Per Øyvind Enger
NeuroImage | 2009
Marius Widerøe; Øystein Olsen; Tina Bugge Pedersen; Pål Erik Goa; Annemieke Kavelaars; Cobi J. Heijnen; Jon Skranes; Ann-Mari Brubakk; Christian Brekken